NASDAQ : XRAY
DENTSPLY SIRONA Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.97B |
| Enterprise Value | 4.06B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Dec 26, 2025 |
Shares
| Measure | Value |
|---|
| Current Share Class | 199.35M |
| Shares Outstanding | 199.35M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 109.74% |
| Float | 187.87M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 6.75 |
| PS Ratio | 0.54 |
| Forward PS | 0.55 |
| PB Ratio | 1.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.80 |
| P/OCF Ratio | 6.19 |
| PEG Ratio | 6.00 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.11 |
| EV / EBITDA | 7.72 |
| EV / EBIT | 22.95 |
| EV / FCF | 28.40 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.63 |
| Quick Ratio | 0.72 |
| Debt / Equity | 1.72 |
| Debt / EBITDA | 3.83 |
| Debt / FCF | 16.27 |
| Interest Coverage | 1.70 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -33.03% |
| Return on Assets (ROA) | 1.96% |
| Return on Invested Capital (ROIC) | 5.12% |
| Return on Capital Employed (ROCE) | 4.40% |
| Weighted Average Cost of Capital (WACC) | 6.04% |
| Revenue Per Employee | $260,214 |
| Profits Per Employee | -$39,000 |
| Employee Count | 14,000 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 2.74 |
Taxes
| Measure | Value |
|---|
| Income Tax | 200.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -21.49% |
| 50-Day Moving Average | 9.68 |
| 200-Day Moving Average | 11.32 |
| Relative Strength Index (RSI) | 60.99 |
| Average Volume (20 Days) | 4,456,372 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 29.82M |
| Short Previous Month | 25.53M |
| Short % of Shares Out | 14.96% |
| Short % of Float | 15.87% |
| Short Ratio (days to cover) | 5.59 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.64B |
| Gross Profit | 1.80B |
| Operating Income | 177.00M |
| Pretax Income | -347.00M |
| Net Income | -546.00M |
| EBITDA | 526.00M |
| EBIT | 177.00M |
| Loss Per Share | -$2.73 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 239.00M |
| Total Debt | 2.33B |
| Net Cash | -2.09B |
| Net Cash Per Share | -$10.47 |
| Equity (Book Value) | 1.35B |
| Book Value Per Share | 6.78 |
| Working Capital | 743.00M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 319.00M |
| Capital Expenditures | -176.00M |
| Depreciation & Amortization | 349.00M |
| Net Borrowing | -146.00M |
| Free Cash Flow | 143.00M |
| FCF Per Share | $0.72 |
Margins
| Measure | Value |
|---|
| Gross Margin | 49.52% |
| Operating Margin | 4.86% |
| Pretax Margin | -9.53% |
| Profit Margin | -14.99% |
| EBITDA Margin | 14.44% |
| EBIT Margin | 4.86% |
| FCF Margin | 3.93% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.16 |
| Dividend Yield | 1.62% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 22.31% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 1.54% |
| Earnings Yield | -27.62% |
| FCF Yield | 7.25% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.40 |
| Price Target Difference | 25.25% |
| Analyst Consensus | Hold |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 0.18% |
| EPS Growth Forecast (3Y) | 0.31% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 18, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.96 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |